Nav: Home

Hesperos' multi-organ 'human-on-a-chip' found effective for long-term toxicology testing

February 21, 2019

(ORLANDO, Fla.) The replacement of animals as test subjects is one step closer to reality with the successful testing of multi-organ "human-on-a-chip" models to recapitulate the 28-day experiments typically used in animals to evaluate the systemic toxicity of drug and cosmetic compounds. As published and featured as a frontispiece in the prestigious peer-reviewed scientific journal Advanced Functional Materials, the microfluidic device with interlinking modules containing human-derived heart, liver, skeletal muscle and nervous system cells was able to maintain cellular viability and record cellular function in real-time for 28 days.

The University of Central Florida (UCF) in collaboration with the Florida biotech firm Hesperos, Inc., has shown that one of its innovative four-organ in vitro (out of body) model systems is able to realistically replicate in vivo (in body) responses to sustained drug dosing of human cells.

"The technology could allow us, in the very near future, to move chronic drug experiments from animal models to these novel human in vitro models," said Hesperos Chief Scientist James J. Hickman, who is a Professor at UCF's NanoScience Technology Center.

This is important because the toxicity and efficacy of new compounds are studied upon both acute (single administration at high concentrations, over a short-term period) and chronic (repeated or continuous administration at lower concentrations, over an extended period) exposures. While organ-on-a-chip models have previously been used for mechanism of action validation (efficacy) and acute toxicity screening, they have not been suitable for long-term studies due to short half-lifes, lack of organ-organ communication, and outcomes that are difficult to extrapolate to human organ functions.

The Hesperos system overcomes these limitations with a model that allows interaction between its tiny organs, cultured in a serum-free blood surrogate solution from real human cells, in a way that realistically replicates system body responses to any compounds introduced to it. It can also non-invasively evaluate the electrical activity of neurons and cardiac cells, as well as the mechanics of cardiac and skeletal muscle contractions. Such monitoring of cellular function is crucial in chronic toxicity testing as it emulates in vivo function.

In order to reach the 28-day testing milestone, Hesperos engineers used computational fluid dynamic modeling to modify their existing multi-organ models. They made them smaller, improved their flow characteristics, and incorporated more functional measurements.

"We have created a valuable tool to model the pharmacokinetics and pharmacodynamics profile of known drugs, in line with ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use) guidelines," Hickman added. "In the future, it could also be used to generate mechanistic models to predict the outcome of unknown drugs, and in other precision medicine applications."

The tool would be especially valuable to the cosmetics industry, where the use of animals to evaluate toxicity of ingredients has already been banned in the EU, and more recently in some parts of the United States.
-end-
About Hesperos:

Hesperos, Inc. is a leader in efforts to characterize an individual's biology with human-on-a-chip microfluidic systems. Founders Michael L. Shuler and James J. Hickman have been at the forefront of every major scientific discovery in this realm, from individual organ-on-a-chip constructs to fully functional, interconnected multi-organ systems. With a mission to revolutionize toxicology testing as well as efficacy evaluation for drug discovery, the company has created pumpless platforms with serum-free cellular mediums that allow multi-organ system communication and integrated computational PKPD modeling of live physiological responses utilizing functional readouts from neurons, cardiac, muscle, barrier tissues and neuromuscular junctions as well as responses from liver, pancreas and barrier tissues. Created from human stem cells, the fully human systems are the first in vitro solutions that accurately utilize in vitro systems to predict in vivo functions without the use of animal models, as featured in Science. More information is available at http://www.hesperosinc.com

Media contact:

Michelle Linn
Bioscribe
774-696-3803
michelle@bioscribe.com

Bioscribe

Related Skeletal Muscle Articles:

Sea urchin protein provides insights into self-assembly of skeletal structures
Calcium carbonate combined with sea urchin proteins form tiny stacks of 'bricks' that creates a structure which provides a tough, exoskeleton defense for the sea creature.
Is the debate over coral skeletal development finally over?
A long-running debate over how coral skeletons are formed may be closer to resolution, as a new study reports that these structures form by a biologically controlled process, not one driven by chemical processes.
A stem cell gene found to command skeletal muscle regeneration
Prox1 gene has long been known to play an important role in fetal development.
Actuators inspired by muscle
To make robots more cooperative and have them perform tasks in close proximity to humans, they must be softer and safer.
A skeletal marker of physiological stress might indicate good, rather than poor, health
One of the skeletal markers that anthropologists use to decipher the past, linear enamel hypoplasia, might need to be looked at in a new light.
IOF launches new resource on rare skeletal disorders
On the occasion of Rare Disease Day, IOF has published a new online resource which provides information on more than 80 of the main rare disorders that affect the skeleton.
Skeletal muscle satellite cells and stem cells
The overall scientific objective of this conference is to provide a forum for cutting-edge work in muscle satellite and stem cells, including regulatory mechanisms controlling normal and abnormal functions of muscle stem cells in regeneration, homeostasis, hypertrophy, aging and disease.
Smooth muscle
The FASEB Smooth Muscle Conference is widely regarded as the premier forum in smooth muscle biology, and thus, attracts internationally recognized leaders in a number of fields.
Nutritional needs for skeletal health change as you age, says new scientific review
Whether you're young or old, the right nutrition can make a difference to your bone health and influence your ability to live an independent, mobile, fracture-free life into your more senior years.
Contrary to previous studies, diabetes affects diaphragm, skeletal muscle cells differently
Previous studies have shown that diabetes adversely affects breathing and respiratory function.

Related Skeletal Muscle Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Jumpstarting Creativity
Our greatest breakthroughs and triumphs have one thing in common: creativity. But how do you ignite it? And how do you rekindle it? This hour, TED speakers explore ideas on jumpstarting creativity. Guests include economist Tim Harford, producer Helen Marriage, artificial intelligence researcher Steve Engels, and behavioral scientist Marily Oppezzo.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".